Skip to main content
. Author manuscript; available in PMC: 2015 Oct 13.
Published in final edited form as: Rev Saude Publica. 2010 Sep 8;44(5):803–811. doi: 10.1590/s0034-89102010005000034

Table 2.

Prevention of mother-to-child transmission interventions provided to women and their newborns. Cities of Rio de Janeiro and Porto Alegre, Southeastern and Southern Brazil, 2000–2002.

Interventions to the newborn – n (%) Rio de Janeiro Porto Alegre Total (n = 140)d,e,f
Labor (n = 17) Postpartum (n = 30)e,f Total (n = 47)e,f Labor (n = 86) Postpartum (n = 7)d Total (n = 93)d
PREP AZTa + NAMb + PEP AZTc 13 (76.5) 13 (27.7) 64 (74.4) 64 (68.8) 77 (55.0)
NAM + PEP AZT 1 (5.9) 10 (33.3) 11 (23.4) 18 (20.9) 7 (100.0) 25 (26.9) 36 (25.7)
NAM only 1 (1.2) 1 (1.1) 1 (0.7)
PEP AZT only 2 (11.8) 20 (66.7) 22 (46.8) 3 (3.5) 3 (3.2) 25 (17.9)
No intervention 1 (5.9) 1 (2.1) 1 (0.7)
a

PREP ZDV: Pre-exposure prophylaxis with intravenous zidovudine.

b

NAM: No breastfeeding while in the maternity hospital.

c

PEP ZDV: Post-exposure prophylaxis with oral zidovudine.

d

Information regarding PREP ZDV and PEP ZDV were not available for one newborn in Porto Alegre (mother tested during labor). This newborn was not included in the table as we could not determine which set of interventions he received (missing data).

e

Information about breastfeeding while in the maternity hospitals was not available for one newborn in Rio de Janeiro. This newborn received PEP AZT (mother tested in the postpartum period). This newborn was not included in the table as we could not determine which set of interventions he received (missing data).

f

One stillbirth and one newborn who died within a few minutes after birth both in Rio de Janeiro were not included in the table.